Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ToposNomos is a private German life-science tools and services company focused on toponomics, a high-dimensional protein-network mapping approach for cells and tissues. The company commercializes its proprietary Imaging Cycler® technology, also described as TIS™ or MUSIC robotics, as hardware, software, consulting, training, and contract research services for biomedical and translational research users. Its platform is designed to map large numbers of proteins in situ across repeated fluorescence-tagging cycles, enabling discovery of combinatorial biomarkers, pathological lead proteins, and spatial protein-network patterns in health and disease. ToposNomos appears to operate primarily as a platform and services business rather than as a therapeutic drug developer, with applications spanning neuroscience, oncology, and broader disease-biology research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ToposNomos.